Skip to main content
EuroGCT
Menu
Close
Help and support
Help and support
FAQ's
Glossary
FAQ's
How is the safety of a new gene therapy determined?
How are gene and cell therapies different to 'traditional' therapies?
Where do embryonic stem cells for research come from?
How is the production of gene and cell therapies different to traditional treatments?
Why do we need gene and cell therapies? How are they different from traditional medicines and treatments?
What is genetic testing?
Is it ethical to use animals in health and scientific research?
What are the roles of regulators in the development of gene and cell therapies?
See all FAQs
Glossary
Accelerated assessment
Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Advanced Therapy Investigational Medicinal Product (ATIMP)
Advanced Therapy Medicinal Product (ATMP)
Advertising
Antibody
See full Glossary
Search
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Select language
Select language
English
Français
Deutsch
Italiano
Polski
Español
Português
Condition
Blood disorders
Sickle Cell Disease
Cardiovascular Disease
Heart Disease
Stroke
Bowel Disease
Cancer
Cystic Fibrosis
Eye Disease
Immune Conditions
Diabetes
Multiple Sclerosis
Kidney Disease
Liver Disease
Lung Disease
Bone and Muscle Conditions
Muscular Dystrophy
Spinal Cord Injuries
Neurological Disorders
Alzheimer's Disease
Cerebral Palsy
Huntington's Disease
Motor Neurone Disease
Parkinson's Disease
Spinal Muscular Atrophy
Skin
Epidermolysis Bullosa
Reproduction and Fertility
Cord Blood
Rare Diseases
Theme
Cell and Gene Fundamentals
Blood Stem Cells
Cord Blood
Embryonic Stem Cells
iPS cells
MSCs
Skin Stem Cells
Current and Potential Uses
Cell Therapy
Gene Therapy
Clinical Trials
CAR-T Therapy
Methods and Tools
Disease Modelling
Organoids
Tissue Engineering
Gene Editing
Reprogramming
Ethics and Society
Patient Involvement
Policy & Regulation
Unproven Treatments
Factsheets
Spotlight on Research
Main navigation
Discover
Discover
Educational Resources Directory
INTENS
LEARN
Research Pathways
Research Pathways
EuroGCT Key Resources
ATMP Engage
CARTALLEU
Actors and Network database
About Us
Contact
Breadcrumb
Home
Current and Potential Uses
Clinical Trials
Clinical Trials
Resources & Factsheets
EuroGCT Resource
What are 'unproven' therapies?
Related Topics
Clinical Trials
Current and Potential Uses
Ethics and Society
Factsheets
MSCs
Policy & Regulation
Unproven Treatments
EuroGCT Resource
Considering a treatment offer?
Related Topics
Cell Therapy
Clinical Trials
Current and Potential Uses
Gene Therapy
Unproven Treatments
Emily's Entourage: CF Clinical Trials Connect
Related Topics
Cystic Fibrosis
Clinical Trials
Patient Involvement
Research
CF Trust: Cystic Fibrosis Trials Tracker
Related Topics
Cystic Fibrosis
Clinical Trials
Patient Involvement
Research
Spotlight on Research: A new way to treat blindness using stem cells
Related Topics
Condition
Eye Disease
Theme
Cell Therapy
Clinical Trials
Spotlight on Research
Taking part in clinical trials: MRI scans
Related Topics
Parkinson's Disease
Clinical Trials
Current and Potential Uses
Patient Involvement
Unproven Treatments
Taking part in clinical trials: MRI and PET
Related Topics
Neurological Disorders
Parkinson's Disease
Clinical Trials
Current and Potential Uses
Patient Involvement
Unproven Treatments
LEARN Study: A checklist for people with Parkinson's Disease considering study participation
Related Topics
Neurological Disorders
Parkinson's Disease
Cell Therapy
Clinical Trials
Current and Potential Uses
Patient Involvement
Unproven Treatments
Support partners in conversation
Related Topics
Neurological Disorders
Parkinson's Disease
Clinical Trials
Patient Involvement
Off medication in Parkinson's Disease: clinical trial participant experiences
Related Topics
Neurological Disorders
Parkinson's Disease
Clinical Trials
Patient Involvement
Pagination
Page
1
Page
2
Page
3
Next page
››
Last page
Last »
